BioLineRx (BLRX) Shares Outstanding (2010 - 2025)
BioLineRx (BLRX) Shares Outstanding (2010 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 6,012.74 Bn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | 47.82 Bn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 118.76 Bn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1.44 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 254.10 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 400.00 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 62.06 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 198.10 Mn |
| 10 | BioLineRx | 7.21 Bn | 7.21 Bn | 154,000.00 | 2.47 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.47 Bn |
| Sep 30, 2025 | 2.61 Bn |
| Jun 30, 2025 | 2.37 Bn |
| Mar 31, 2025 | 2.22 Bn |
| Dec 31, 2024 | 1.20 Bn |
| Sep 30, 2024 | 47.98 Bn |
| Jun 30, 2024 | 47.90 Bn |
| Mar 31, 2024 | 43.46 Bn |
| Dec 31, 2023 | 38.53 Bn |
| Sep 30, 2023 | 37.16 Bn |
| Jun 30, 2023 | 36.92 Bn |
| Mar 31, 2023 | 36.92 Bn |
| Dec 31, 2022 | 30.96 Bn |
| Sep 30, 2022 | 29.63 Bn |
| Jun 30, 2022 | 28.61 Bn |
| Mar 31, 2022 | 28.61 Bn |
| Dec 31, 2021 | 26.52 Bn |
| Sep 30, 2021 | 28.34 Bn |
| Jun 30, 2021 | 26.77 Bn |
| Mar 31, 2021 | 22.38 Bn |